Blueprint for imaging in biomedical research

Radiology

Volumn 244, Issue 1, 2007, Pages 12-27

  Ehman, Richard L ^a   Hendee, William R ^b   Welch, Michael J ^c   Dunnick, N Reed ^d   Bresolin, Linda B ^e   Arenson, Ronald L ^f   Baum, Stanley ^g   Hricak, Hedvig ^h   Thrall, James H ⁱ  

^a MAYO CLINIC   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e Radiological Society of North America   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ANATOMY; BIOENGINEERING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ELECTRON MICROSCOPY; FUNDING; GOVERNMENT; HUMAN; IMAGING SYSTEM; KNOWLEDGE; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICAL TECHNOLOGY; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW;

BIOMEDICAL ENGINEERING; BIOMEDICAL RESEARCH; DIAGNOSTIC IMAGING; NATIONAL INSTITUTES OF HEALTH (U.S.); UNITED STATES;

EID: 34250894515     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2441070058     Document Type: Review

References (175)

1. NIH roadmap for medical research. National Institutes of Health Web site. http: //www.nihroadmap.nih.gov/index.asp. Accessed October 4, 2006.
2. Institutional clinical and translational science award (U54). National Institutes of Health Web site. http://grants.nih.gov /grants/guide/rfa-files/ RFA-RM-07-002.html. Accessed October 4, 2006.
3. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy of Sciences 2001. Institute of Medicine Web site. http: //www.iom.edu/?id=12736. Accessed October 4, 2006.
4. Raichle ME, Mintun MA. Brain work and brain imaging. Annu Rev Neurosci 2006;29: 449-476.
5. Fenchel M, Scheule AM, Stauder NJ, et al. Atherosclerotic disease: whole-body imaging with MR system with 32 receiver channels and total-body surface coil technology - initial clinical results. Radiology 2005; 238:280-291.
6. Atri M. New technologies and directed agents for applications of cancer imaging. J Clin Oncol 2006;24(20):3299-3308.
7. Barentsz J, Takahashi S, Oyen W, et al. Commonly used imaging techniques for diagnosis and staging. J Clin Oncol 2006; 24(20):3234-3244.
8. Schnall M, Rosen M. Primer on imaging technologies for cancer. J Clin Oncol 2006; 24(20):3225-3233.
9. Dormann D, Weijer CJ. Imaging of cell migration. EMBO J 2006;25(15):3480-3493.
10. Hendee WR, Gazelle GS. Biomedical imaging research opportunities workshop III: a white paper. Ann Biomed Eng 2006;34: 188-198.
11. Nichols L, Pike VW, Cai L, Innis RB. Imaging and in vivo quantitation of beta-amyloid: an exemplary biomarker for Alzheimer's disease? Biol Psychiatry 2006; 59(10):940-947.
12. Sorensen AG. Magnetic resonance as a cancer imaging biomarker. J Clin Oncol 2006; 24(20):3274-3281.
13. Schoenhagen P, Nissen SE. Intravascular ultrasonography: using imaging end points in coronary atherosclerosis trials. Cleve Clin J Med 2005;72(6):487-489, 493-496.
14. Roentgen WC. On a new kind of rays (translated by Stanton A). Nature 1896;53: 274-277.
15. Noel A, Thibault F. Digital detectors for mammography: the technical challenges. Eur Radiol 2004;14:1990-1998.
16. Xu T, Ducote JL, Wong JT, Molloi S. Feasibility of real time dual-energy imaging based on a flat panel detector for coronary artery calcium quantification. Med Phys 2006;33(6):1612-1622.
17. Yuasa T, Sugiyama H, Zhong Z, et al. High-pass-filtered diffraction microtomography by coherent hard x rays for cell imaging: theoretical and numerical studies of the imaging and reconstruction principles. J Opt Soc Am A Opt Image Sci Vis 2005;22(12): 2622-2634.
18. Snigireva I, Snigirev A. X-Ray microanalytical techniques based on synchrotron radiation. J Environ Monit 2006;8(1):33-42.
19. Pannu HK, Jacobs JE, Lai S, Fishman EK. Coronary CT angiography with 64 MDCT: assessment of vessel visibility. AJR Am J Roentgenol 2006;187:119-126.
20. Sablayrolles JL, Al Attar N, Nataf P. New trends in non-invasive coronary angiography with multislice CT. Surg Technol Int 2004;13:205-213.
21. Rubin GD. MDCT imaging of the aorta and peripheral vessels. Eur J Radiol 2003; 45(suppl 1):S42-S49.
22. Ueno J, Murase T, Yoneda K, Tsujikawa T, Sakiyama S, Kondoh K. Three-dimensional imaging of thoracic diseases with multi-detector row CT. J Med Invest. 2004;51(3-4): 163-170.
23. Murakami T, Onishi H, Mikami K, et al. Determining the optimal timing for early arterial phase hepatic CT imaging by measuring abdominal aortic enhancement in variable contrast injection protocols. J Comput Assist Tomogr 2006;30:206-211.
24. Falchi M, Rollaudi GA. CT of pelvic fractures. Eur J Radiol 2004;50(1):96-105.
25. Pilleul F, Penigaud M, Milot L, Sauriu JC, Chayvialle JA, Valette PJ. Possible small-bowel neoplasms: contrast-enhanced and water-enhanced multidetector CT enteroclysis. Radiology 2006;241:796-801.
26. Perrier A, Roy PM, Sanchez O, et al. Multi-detector-row computed tomography in suspected pulmonary embolism. N Engl J Med 2005;352(17):1760-1768.
27. Wallace MB, Sullivan D, Rustgi AK; AITGN Symposium Faculty. Advanced imaging and technology in gastrointestinal neoplasia: summary of the AGA-NCI Symposium October 4-5, 2004. Gastroenterology 2006; 130(4):1333-1342.
28. Ding YS, Galley SJ. Positron radiopharmaceuticals and their chemistry. In: Henkin RE, Bova D, Dillehay G, et al, eds. Nuclear medicine. 2 vols. 2nd ed. Philadelphia, Pa: Mosby Elsevier, 2006.
29. Gropler RJ, Soto P. Recent advances in cardiac positron emission tomography in the clinical management of the cardiac patient. Curr Cardiol Rep 2004;6(1):20-26.
30. Fletcher JW. Positron emission tomography: applications in oncology. In: Henkin RE, Bova D, Dillehay G, et al, eds. Nuclear medicine. 2 vols, 2nd ed. Philadelphia, Pa: Mosby Elsevier, 2006.
31. Prince MR, Meaney JF. Expanding role of MR angiography in clinical practice. Eur Radiol 2006;16(suppl 2):B3-B8.
32. Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation 2005;112(9):1362-1374.
33. Ogawa S, Lee TM, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 1990;87:9868-9872.
34. Kwong KK, Belliveau JW, Chesler DA. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci U S A 1992; 89:5675-5679.
35. Matthews PM, Honey GD, Bullmore ET. Applications of fMRT in translational medicine and clinical practice. Nat Rev Neurosci 2006;7(9):732-744.
36. Brasch R, Turetschek K. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. Eur J Radiol 2000;34(3):148-155.
37. Hussain UK, Chenevert TL, Londy FJ, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display - early experience. Radiology 2005;237(3):1048-1055. [Published correction appears in Radiology 2006;238(3):1078.]
38. Jansen JF, Baekes WH, Nicolay K, Kooi ME. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 2006;240(2):318-332.
39. Sakuma H, Higgins CB. Magnetic resonance measurement of coronary blood flow. Acta Paediatr Suppl 2004;93(446): 80-85.
40. Petersen KT, Zimine I, Ho YC, Golay X. Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques. Br J Radiol 2006;79(944):688-701.
41. Castillo E, Lima JA, Bluemke DA. Regional myocardial function: advances in MR imaging and analysis. RadioGraphics 2003; 23(Spec Issue):S127-S140.
42. Provenzale JM, Mukundan S, Barboriak DP. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006;239(3):632-649.
43. Rouviere O, Yin M, Dresner MA, et al. MR elastograpby of the liver: preliminary results. Radiology 2000;240(2):440-448.
44. Mori S, Zhang J. Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 2006; 51(5):527-539.
45. Merritt CRB. Physics of ultrasound. In: Rumack CM, Wilson S, Charboneau JM, Johnson J, eds. Diagnostic ultrasound. 3rd ed. St. Louis, Mo: Elsevier Mosby, 2005.
46. Wells PN. Ultrasound imaging. Phys Med Biol 2006;51(13):R83-R98.
47. Baroncini LA, Pazin Filho A, Murta Junior LO, et al. Ultrasonic tissue characterization of vulnerable carotid plaque: correlation between videodensitometric method and histological examination. Cardiovasc Ultrasound 2006;4:32.
48. Di Bello V, Santini F, Di Cori A, et al. Obesity cardiomyopathy: is it a reality? an ultrasonic tissue characterization study. J Am Soc Echocardiogr 2006;19(8):1063-1071.
49. Thomas A, Fischer T, Frey H, et al. Real-time elastograpby: an advanced method of ultrasound - first results in 108 patients with breast lesions. Ultrasound Obstet Gynecol 2006;28(3):335-340.
50. Murtagh J, Foerster V. Transient elastography (FibroScan) for non-invasive assessment of liver fibrosis. Issues Emerg Health Technol 2006;90:1-4.
51. Gomez-Dominguez K, Mendoza J, Rubio S, Moreno-Monteagudo JA, Garcia-Buey L, Moreno-Otero R. Transient elastograpby: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol Ther 2006;24(3):513-518.
52. Saftoiu A, Vilman P. Endoscopic ultrasound elastograpby: a new imaging technique for the visualization of tissue elasticity distribution. J Gastrointestin Liver Dis 2006;15(2): 161-165.
53. Klibanov AL. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol 2006;41(3):354-362.
54. Dwivedi G, Ahmed-Hayat S, Janardhanan R, Senior R. Myocardial contrast echocardiography: role in clinical cardiology. Curr Vasc Pharmacol 2006;4:229-237.
55. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003; 7(5):626-634.
56. Wilkinson JM, Kuok MH, Adamson G. Biomedical applications of optical imaging. Med Device Technol 2004;15(10):22-24.
57. Zhang Z, Achilefu S. Spectral properties of pro-multimodal imaging agents derived from a NIR dye and a metal chelator. Photochem Photobiol 2005;81(6):1499-1504.
58. Nehrke K. Intracellular pH measurements in vivo using green fluorescent, protein variants. Methods Mol Biol 2006;351:223-239.
59. Tavare JM, Fletcher LM, Welsh GI. Using green fluorescent protein to study intracellular signalling. J Endocrinol 2001;170(2): 297-306.
60. Ye Y, Bloch S, Xu B, Achilefu S. Design, synthesis and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors. J Med Chem 2006;49(7): 2268-2275.
61. Day RN, Schaufele F. Imaging molecular interactions in living cells. Mol Endocrinol 2005;19(7):1675-1680.
62. Garini Y, Vermolen BJ, Young IT. From micro to nano: recent advances in high-resolution microscopy. Curr Opin Biotechnol 2005;16(1):3-12.
63. Egner A, Hell SW. Fluorescence microscopy with super-resolved optical sections. Trends Cell Biol 2005;15(4):207-215.
64. Conchello JA, Lichtman JW. Optical sectioning microscopy. Nat Methods 2005; 2(12):920-931.
65. McDonald KL, Auer M. High-pressure freezing, cellular tomography, and structural cell biology. Biotechniques 2006; 41(2):137-143.
66. McIntosh R, Nicastro D, Mastronarde D. New views of cells in 3D: an introduction to electron tomography. Trends Cell Biol 2005;15(1):43-51.
67. Hinterdorfer P, Dufrene YF. Detection and localization of single molecular recognition events using atomic force microscopy. Nat Methods 2006;3(5):347-355.
68. Bunk S. Better microscopes will be instrumental in nanotechnology development. Nature 2001;410(6824):127-129.
69. Makela JP, Forss N, Jaaskelainen J, Kirveskari E, Korvenoja A, Paetau R. Magnetoencephalography in neurosurgery. Neurosurgery 2000;59(3):493-510.
70. Hillebrand A, Singh KD, Holliday IE, Furlong PL, Barnes GR. A new approach to neuroimaging with magnetoencephalography. Hum Brain Mapp 2005;25(2):199-211.
71. Haberkorn W, Steinhoff V, Burghoff M, Kosch O, Morguet A, Koch H. Pseudo current density maps of electrophysiological heart, nerve or brain function and their physical basis. Biomagn Res Technol 2006; 4:5.
72. Xu Y, Wang LV. Rhesus monkey brain imaging through intact skull with thermoacoustic tomography. IEEE Trans Ultrason Ferroelectr Freq Control 2006;53(3): 542-548.
73. Ku G, Fornage BD, Jin X, Xu M, Hunt KK, Wang LV. Thermoacoustic and photoacoustic tomography of thick biological tissues toward breast imaging. Technol Cancer Res Treat 2005;4(5):559-566.
74. Wang X, Chamberland DL, Carson PL, et al. Imaging of joints with laser-based photoacoustic tomography: an animal study. Med Phys 2006;33(8):2691-2697.
75. Bremer C, Ntziachristos V, Weitkamp B, Theilmeier G, Heindel W, Weissleder R. Optical imaging of spontaneous breast tumors using protease sensing 'smart' optical probes. Invest Radiol 2005;40(6):321-327.
76. Andrews RJ, Mah RW. The NASA Smart Probe Project for real-time multiple microsensor tissue recognition. Stereotact Funct Neurosurg 2003;80(1-4):114-119.
77. Campa MJ, Serlin SB, Patz EF Jr. Development of novel tumor imaging agents with phage-display combinatorial peptide libraries. Acad Radiol 2002;9(8):927-932.
78. Landou LA, Deutscher SL. Combinatorial discovery of tumor targeting peptides using phage display. J Cell Biochem 2003;90(3): 509-517.
79. Bergstrom M, Awad R, Estrade S, et al. Autoradiography with positron emitting isotopes in positron emission tomography tracer discovery. Mol Imaging Biol 2003; 5(6):390-396.
80. Kolb HC, Sharpless KB. The growing impact of click chemistry on drug discovery. Drug Discov Today 2003;8(24):1128-1137.
81. Wang J, Uttamchandani M, Li J, Hu M, Yao SQ. "Click" synthesis of small molecule probes for activity-based fingerprinting of matrix metalloproteases. Chem Commun (Camb) 2006;36:3783-3785.
82. Speers AE, Cravatt BF. Profiling enzyme activities in vivo using click chemistry methods. Chem Biol 2004; 11(4):535-546.
83. Zalutsky MR. Potential of immuno-positron emission tomography for tumor imaging and immunotherapy planning. Clin Cancer Res 2006;12(7 pt 1):1958-1960.
84. Price JH, Goodacre A, Halm K, et al. Advances in molecular labeling, high throughput imaging and machine intelligence portend powerful functional cellular biochemistry tools. J Cell Biochem Suppl 2002;39: 194-210.
85. Lee CC, Sui G, Elizarov A, et al. Multistep synthesis of a radiolabeled imaging probe using integrated microfluidics. Science 2005;310(5753):1793-1796.
86. Gillies JM, Prenant C, Chimon GN, et al. Microfluidic reactor for the radiosynthesis of PET radiotracers. Appl Radiat Isot 2006; 64(3):325-332.
87. Liu Y, Miyoshi H, Nakamura M. Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. J Control Release 2006;114(1):89-99.
88. Burns PN. Microbubble contrast for ultrasound imaging: where, how and why? In: Rumack CM, Wilson S, Charboneau JM, Johnson J, eds. Diagnostic ultrasound. 3rd ed. St. Louis, Mo: Elsevier Mosby, 2005.
89. Morawski AM, Lanza GA, Wickline SA. Targeted contrast agents for magnetic resonance imaging and ultrasound. Curr Opin Biotechnol 2005;16(1):89-92.
90. Hutcheson GD. The first nanochips. Sci Am 2004;290(4):76-83.
91. Kricka LJ. Microchips, microarrays, biochips and nanochips: personal laboratories for the 21st century. Clin Chim Acta 2001; 307(1-2):219-223.
92. Arbab AS, Liu W, Frank JA. Cellular magnetic resonance imaging: current status and future prospects. Expert Rev Med Devices 2006;3(4):427-439.
93. Knauth M, Fgelhof T, Roth SU, Wirtz CR, Sartor K. Monocrystalline iron oxide nanoparticles: possible solution to the problem of surgically induced intracranial contrast enhancement in intraoperative MR imaging. AJNR Am J Neuroradiol 2001; 22(1):99-102.
94. Moore A, Weissleder R, Bogdanov A Jr. Uptake of dextran-coated monocryslalline iron oxides in tumor cells and macrophages. J Magn Reson Imaging 1997;7(6): 1140-1145.
95. Veiseh O, Sun C, Gunn J, et al. Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett 2005;5(6):1003-1008.
96. Hieke BJ, Stephens AW. Escort aptamers: a delivery service for diagnosis and therapy. J Clin Invest 2000;106(8):923-928.
97. Leary SP, Liu CY, Yu C, Apuzzo ML. Toward the emergence of nanoneurosurgery. I. Progress in nanoscience, nanotechnology, and the comprehension of events in the mesoscale realm. Neurosurgery 2005; 57(4):606-634.
98. Sun X, Rossin R, Turner JL, et al. An assessment of the effects of shell cross-linked nanoparticle size, core composition and surface PEGylation on in vivo biodistribution. Biomacromolecules 2005;6:2541-2554.
99. Rossin R, Pan D, Kai Q, et al. 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling and biologic evaluation. J Nucl Med 2005;46: 1210-1218.
100. Portney NG, Ozkan M. Nano-oncology: drug delivery, imaging, and sensing. Anal Bioanal Chem 2006;384(3):620-630.
101. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor- quantum dots. Nat Biotechnol 2004;22(8):969-976.
102. Selb J, Joseph DK, Boas DA. Time-gated optical system for depth-resolved functional brain imaging. J Biomed Opt 2006; 11(4):044008. doi:10.1117/1. 2337320. Published August 31, 2006. Accessed November 14, 2006.
103. Ntziachristos V, Ripoll J, Wang LV, Weissleder R. Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol 2003;23(3):313-320.
104. Schnall MD. Breast MR imaging. Radiol Clin North Am 2003;41(1):43-50.
105. Pathak AP. Magnetic resonance imaging of tumor physiology. Methods Mol Med 2006; 124:279-297.
106. Neeman M, Dafni H. Structural, functional, and molecular MR imaging of the microvasculature. Annu Rev Biomed Eng 2003;5: 29-56.
107. Yokosawa K, Sasaki K, Umemura S, et al. Intracorporeal imaging and differentiation of living tissue with an ultra-high-frequency ultrasound probe. Ultrasound Med Biol 2000;26(4):503-507.
108. Liang HD, Blomley MJ. The role of ultrasound in molecular imaging. Br J Radiol 2003;76(suppl 2):S140-S150.
109. Basser PJ. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed 1995;8(7-8):333-344.
110. Westin MCF, Maier SE, Mamata H, Nabavi A, Jolesz FA, Kikinis R. Processing and visualization for diffusion tensor MRI. Med Image Anal 2002;6(2):93-108.
111. Frank JA, Anderson SA, Kalsih H, et al. Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging. Cytotherapy 2004; 6(6):621-625.
112. Williams KA. Clinical applications of myocardial perfusion imaging. In: Henkin RE, Bova D, Dillehay G, et al, eds. Nuclear medicine. 2 vols. 2nd ed. Philadelphia, Pa: Mosby Elsevier, 2006.
113. Raichle MF. Behind the scenes of functional brain imaging: a historical and physiological perspective. Proc Natl Acad Sci U S A 1998; 95:765-772.
114. Klunk WE, Engler II, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound B. Ann Neurol 2004;53(3):306-319.
115. Weissleder R. Molecular imaging: exploring the next frontier. Radiology 1999;212: 609-661.
116. Wagner HN Jr. From molecular imaging to molecular medicine. J Nucl Med 2006; 47(8):13N-39N.
117. Lucignani G, Ottohrini L, Martelli C, Resoigno M, Clerici M. Molecular imaging of cell-mediated cancer immunotherapy. Trends Biotechnol 2006;24(9):410-418.
118. Sharkey RM, Goldenberg DM. Targeted therapy of cancer: new prospects for antibodies and immunoconjugates. CA Cancer J Clin 2006;56(4):226-243.
119. Pomper MG. Translational molecular imaging for cancer. Cancer Imaging 2005;5(spec no A):S16-S26.
120. Mathis CA, Klunk WE, Price JC, DeKosky ST. Imaging technology for neurodegenerative diseases: progress toward detection of specific pathologies. Arch Neurol 2005;62: 196-200.
121. Arenson RL, Andriole KP, Avrin DE, Gould RG. Computers in imaging and health care: now and in the future. J Digit Imaging 2000; 13(4):145-156.
122. Andriole K. Overview of medical imaging information. In: Wolbarst AB, Zamenhof RG, Hendee WR, eds. Advances in medical imaging. Madison, Wis: Medical Physics Publishing, 2006; 201-228.
123. Fhager A, Hashemzadeh P, Persson M. Reconstruction quality and spectral content of an electromagnetic time-domain inversion algorithm. IEEE Trans Biomed Eng 2006; 53(8):1594-1604.
124. Katsevich A. Analysis of an exact inversion algorithm for spiral cone-beam CT. Phys Med Biol 2002;47(15):2583-2597.
125. Kim J, Cai W, Feng D, Wu H. A new way for multidimensional medical data management: volume of interest (VOI)-based retrieval of medical images with visual and functional features. IEEE Trans Inf Technol Biomed 2006;10(3):598-607.
126. Rosset A, Spadola L, Pysher L, Ratib O. Informatics in radiology (infoRAD): navigating the fifth dimension: innovative interface for multidimensional multimodality image navigation. RadioGraphics 2006;26(1): 299-308.
127. Jin JY, Ryu S, Faber K, et al. 2D/3D image fusion for accurate target and localization and evaluation of a mask-based stereotactic system in fractionated stereotactic radiotherapy of cranial lesions. Med Phys 2006; 33(12):4557-4566.
128. Kopelman D, Inbar Y, Hananuel A, et al. Magnetic resonance-guided focused ultrasound surgery (MRgFUS): ablation of liver tissue in a porcine model. Eur J Radiol 2006;59:157-162.
129. Mowatt G, Bower DJ, Brebner JA, Cairns JA, Grant AM, McKee L. When is the 'right' time to initiate an assessment of a health technology? Int J Technol Assess Health Care 1998;14(2):372-386.
130. Clancy CM. Getting to 'smart' health care. Health Aff (Millwood) 2006;25:w589-w592. doi:10.1377/hlthaff.25.w589. Published November 7, 2006. Accessed November 14, 2006.
131. Wang DS, Dake MD, Park JM, Kuo MD. Molecular imaging: a primer for interventionalists and imagers. J Vasc Interv Radiol 2006;17(9):1405-1423.
132. Heckl S, Pipkorn R, Nagele T, Vogel U, Kuker W, Voight K. Molecular imaging: bridging the gap between neuroradiology and neurohistology. Histol Histopathol 2004;19(2):651-668.
133. Juillerat-Jeanneret L, Schmitt E. Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: looking for the grail. Med Res Rev doi: 10.1002/med.20086. Published online October 4, 2006. Accessed November 14, 2006.
134. Wong JY. Systemic targeted radionuclide therapy: potential new areas. Int J Radiat Oncol Biol Phys 2006;66(2 suppl):S74-S82.
135. Jones HA. Inflammation imaging. Proc Am Thorac Soc 2005;2(6):545-548.
136. Helms MW, Brandt BH, Contag CH. Options for visualizing metastatic disease in the living body. Contrib Microbiol 2006;13: 209-231.
137. Xu K, Ernst M, Goldman D. Imaging genomics applied to anxiety, stress response, and resiliency. Neuroinformatics 2006;4(1):51-64.
138. Walker C, du Plessis DG, Fildes D, et al. Correlation of molecular genetics with molecular and morphological imaging in gliomas with an oligodendroglial component. Clin Cancer Res 2004;10:7182-7191.
139. Zaccolo M, Cesetti T, Di Benedetto G, et al. Imaging the cAMP-dependent signal transduction pathway. Biochem Soc Trans 2005; 33(pt 6):1323-1326.
140. Zaccolo M, Pozzan T. Imaging signal transduction in living cells with GFP-based probes. IUBMB Life 2000;49(5):375-379.
141. Haberkorn U, Altmann A, Mier W, Eisenhut M. Impact of functional genomics and proteomics on radionuclide imaging. Semin Nucl Med 2004;34(1):4-22.
142. Demuro A, Parker I. Optical single-channel recording: imaging Ca2+ flux through individual ion channels with high temporal and spatial resolution. J Biomed Opt 2005; 10(1):11002.
143. de Boer J, van Blitterswijk C, Eowik C. Bioluminescent imaging: emerging technology for non-invasive imaging of bone tissue engineering. Biomaterials 2006;27(9): 1851-1858.
144. Mortimer JE, Dehdashti E, Siegel BA, Trinkaus K, Katzenellenbogen JA, Welch MJ. Metabolic flare: indicator of hormone responsiveness in advanced breast cancer. J Clin Oncol 2001;19:2797-2803.
145. Dose Schwarz J, Bader M, Jenicke E, Hemminger G, Janicke F, Avril N. Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET. J Nucl Med 2005;46(7):1144-1150.
146. Dehdashti F, Picus J, Michalski JM, et al. Positron tomographic assessment of androgen receptors in prostatic carcinoma. Eur J Nucl Med Mol Imaging 2005;32:344-350.
147. Larson SM. The future of nuclear medicine: molecular imaging and radiotherapy. In: Henkin RE, Bova D, Dillehay G, et al, eds. Nuclear medicine. 2 vols. 2nd ed. Philadelphia, Pa: Mosby Elsevier, 2006.
148. Erturk SM. CT evaluation of gastrointestinal stromal tumors treated with imatinib mesylate. AJR Am J Roentgenol 2005; 185(5):1366; author reply 1366-1367.
149. Eckelman WC. The use of gene-manipulated mice in the validation of receptor binding radiotracer. Nucl Med Biol 2003; 30(8):851-860.
150. Kim CF, Jackson EL, Kirsch DG, et al. Mouse models of human non-small-cell lung cancer: raising the bar. Cold Spring Harb Symp Quant Biol 2005;70:241-250.
151. Guidance for industry, investigators and reviewers: exploratory IND studies. U.S. Food and Drug Administration Web site. http://www.fda.gov/cder/ guidance/index.htm. Accessed November 14, 2006.
152. Bergstrom M, Grahnen A, Langstrom B. Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development. Eur J Clin Pharmacol 2003;59(5-6):357-366.
153. Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol 2006;24(20): 3293-3298.
154. Weber WA. Positron emission tomography as an imaging biomarker. J Clin Oncol 2006;24(20):3282-3292.
155. Workman P, Aboagye EO, Chung YL, et al. Cancer Res UK Pharmacodynamic/Pharmacokinetic Technologies Advisory Committee. Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies. J Natl Cancer Inst 2006;98(9):580-598.
156. Kantarci K, Jack CR Jr. Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease. NeuroRx 2004;1(2):196-205.
157. Spencer TJ, Biederman J, Ciccone PE, et al. PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short-and long-acting oral methylphenidate. Am J Psychiatry 2006;163(3):387-395.
158. Jain KK. Role of nanobiotechnology in developing personalized medicine for cancer. Technol Cancer Res Treat. 2005;4(6):645-650.
159. Workman P. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones. Cancer Chemother Pharmacol 2003;52(suppl 1):S45-S56.
160. Hernes TA, Ommedal S, Lie T, Lindseth F, Lango T, Unsgaard G. Stereoscopic navigation-controlled display of preoperative MR1 and intraoperative 3D ultrasound in planning and guidance of neurosurgery: new technology for minimally invasive image-guided surgery approaches. Minim Invasive Neurosurg 2003;46(3):129-137.
161. Rygh OM, Cappelen J, Selbekk T, Lindseth F, Hernes TA, Unsgaard G. Endoscopy guided by an intraoperative 3D ultrasound-based neuronavigation system. Minim. Invasive Neurosurg 2006;49(1):1-9.
162. Jolesz EA. Future perspectives for intraoperative MRI. Neurosurg Clin N Am 2005; 16(1):201-213.
163. Gallagher AG, Smith CD. From the operating room of the present to the operating room of the future: human factors lessons learned from the minimally invasive surgery revolution. Semin Laparosc Surg 2003;10(3):127-139.
164. Reijnen MM, Zcebregts CJ, Meijerink WJ. Future of operating rooms. Surg Technol Int 2005;14:21-27.
165. Marobn MR, Hanly EJ. Twenty-first century surgery using twenty-first century technology: surgical robotics. Curr Surg 2004;61(5):466-473.
166. Camarillo DB, Krummel TM, Salisbury JK Jr. Robotic technology in surgery: past, present, and future. Am J Surg 2004; 188(4A suppl):2S-15S.
167. Leichner PK, Akabani G, Colcher D, et al. Patient-specific dosimetry of indium-111-and yttrium-90 labeled monoclonal antibody CC49. J Nucl Med 1997;38:512-516.
168. Liu A, Williams L, Lopatin G, Yamauchi D, Wong J, Raubitschek A. A radionuclide imaging and therapy treatment planning dose estimation system (RTDS). J Nucl Med 1999;40:1151-1153.
169. Weber WA. Use of PET for monitoring cancer therapy and for predicting outcome. J Nucl Med 2005;46(6):983-995.
170. Callstrom MR, Charboneau JW. Percutaneous ablation: safe, effective treatment of bone tumors. Oncology (Williston Park) 2005;19(11 suppl 4):22-26.
171. Boss A, Clasen S, Kuczyk M, Schick F, Pereira PL. Image-guided radiofrequency ablation of renal cell carcinoma. Eur Radiol 2007;17(3):725-733.
172. Haemmerich D, Laeseke PF. Thermal tumour ablation: devices, clinical applications and future directions. Int J Hyperthermia 2005;21(8):755-760.
173. Harrod-Kim P. Tumor ablation with photodynamic therapy: introduction to mechanism and clinical applications. J Vasc Interv Radiol 2006;17(9):1441-1448.
174. Jolesz FA, Hynynen K, McDannold N, Tempany C. MR imaging-controlled focused ultrasound ablation: a noninvasive image-guided surgery. Magn Reson Imaging Clin N Am 2005;13(3):545-560.
175. Wu F. Extracorporeal high intensity focused ultrasound in the treatment of patients with solid malignancy. Minim Invasive Ther Allied Technol 2006;15(1):26-35.